An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Versus Concentration Controlled Cellcept® Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Ciclosporin; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms OptiCept
- Sponsors Roche
- 01 Jul 2009 Results published in the American Journal of Transplantation.
- 16 Feb 2008 Status changed from in progress to completed.
- 28 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History